Lanean...
2443. Searching for the Optimal Treatment Regimen for Metallo-β-Lactamase Producing Enterobacteriaceae: Aztreonam Plus Ceftazidime–Avibactam vs. Aztreonam Plus Meropenem–Vaborbactam
BACKGROUND: Pathogens harboring metallo-β-lactamase (MBL) enzymes pose a large threat to public health. Aztreonam (ATM) is not hydrolyzed by MBLs but is inactivated by other β-lactamases, which are often co-harbored in MBL-producers. Ceftazidime/avibactam (CAZ/AVI) and meropenem/vaborbactam (MER/VBR...
Gorde:
| Argitaratua izan da: | Open Forum Infect Dis |
|---|---|
| Egile Nagusiak: | , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Oxford University Press
2018
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6254777/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofy210.2096 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|